Bio-Rad’s PROTEAN® i12™ IEF System Wins 2012 Laboratory Equipment Readers’ Choice Award

Date: 
3/13/12
PROTEAN i12
The PROTEAN i12 IEF system can simultaneously run up to 12 IPG strips in 12 independently programmed lanes — an industry first.

Laboratory Equipment 2012 Readers' Choice Award

Hercules, CA — March 13, 2012 — Bio-Rad Laboratories, Inc.’s PROTEAN i12 IEF system won a Laboratory Equipment Readers’ Choice Award in the Basic Lab Equipment category. The award will be presented today at a special reception during the Pittcon Conference & Expo 2012 being held at the Orange County Convention Center in Orlando, FL.

“The PROTEAN i12 IEF system individually controls each of its 12 lanes, allowing researchers to generate reproducible 2-D gels in less time and with total confidence,” said Renee Lemaire-Adkins, Bio-Rad Marketing Manager, Lab Separations Division. “It is a great honor to have our IEF technology recognized by the researchers and laboratory professionals who compose Laboratory Equipment’s readership.”

The 4th annual award celebrates “excellence in product design and performance for the tools and materials used by scientists and engineers in research laboratories.” Laboratory Equipment readers voted for products online.

The PROTEAN i12 IEF system is the industry’s only isoelectric focusing (IEF) system designed to simultaneously run up to 12 immobilized pH gradient (IPG) strips in 12 independently programmed lanes, which allows users to confidently run 12 different conditions at one time. Although many available IEF systems have multiple lanes, all but the PROTEAN i12 system depend on a single power supply, allowing only one set of conditions to be run at a time.

Visit http://bit.ly/proteani12pr or Bio-Rad’s Pittcon Booth #1412 to learn more about the PROTEAN i12 IEF system. You can find more about the Laboratory Equipment Reader’s Choice Award at http://bit.ly/2012readerschoice.

About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) has remained at the center of scientific discovery for more than 50 years, manufacturing and distributing a broad range of products for the life science research and clinical diagnostic markets. The Company is renowned worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies, for its commitment to quality and customer service. Founded in 1952, Bio-Rad is headquartered in Hercules, California, and serves more than 100,000 research and industry customers worldwide through its global network of operations. The Company employs over 7,100 people globally and had revenues exceeding $2 billion in 2011. For more information, visit www.bio-rad.com.

This release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements generally can be identified by the use of forward-looking terminology such as, “believe,” “expect,” “may,” “will,” “intend,” “estimate,” “continue,” or similar expressions or the negative of those terms or expressions. Such statements involve risks and uncertainties, which could cause actual results to vary materially from those expressed in or indicated by the forward-looking statements. For further information regarding the Company's risks and uncertainties, please refer to the “Risk Factors” in the Company’s public reports filed with the Securities and Exchange Commission, including the Company’s most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. The Company cautions you not to place undue reliance on forward-looking statements, which reflect an analysis only and speak only as of the date hereof. Bio-Rad Laboratories, Inc., disclaims any obligation to update these forward-looking statements.

For more information contact:
Katy McGirr
Bio-Rad Laboratories, Inc.
510-741-6548
Katy_McGirr@bio-rad.com

Ken Li
Chempetitive Group
312-997-2436 x 109
kli@chempetitive.com